摘要
Objective:To explore the dose-effect relationship of Astragalus granule(AG) on improving the quality of life(QOL) of the patients with chronic heart failure(CHF).Methods:Ninety CHF patients of Fei(肺)-qi deficiency and/or Xin(心)-Shen(肾) yang-deficiency syndromes were equally randomized divided with a random number table into three groups;they received the high(7.5 g),moderate(4.5 g),and low dosage(2.25 g) of AG orally taken twice a day,respectively,and 4 mg of perindopril tablet once a day for 30 successive days.The heart function grade,patients' left ventricular ejection fraction(LVEF) and walking distance in 6 min(6mWD) were measured before and after treatment,and the patients' QOL was scored by the Minnesota Questionnaire for QOL evaluation in the patients with CHF at the same time.Results:The heart function grades of all the three groups after treatment were improved compared with those before treatment,but the improvements in high-dose group and moderate dose group were better than that in the low dose group(P0.05).LVEFs were increased significantly in all the three groups,but the improvements in the high-dose group(59.42%±7.50%) and moderate dose group(61.98%±6.82%) were better than that in the low dose group(51.45%±6.80%,P0.01); the 6mWDs in the all groups were also significantly increased(P0.01),up to 419.80136.23 m,387.15134.13 m, and 317.69±39.97 m,respectively;and Minnesota scores in them were lowered to 29.59±4.69 scores,35.74±5.89 scores,and 42.78±6.06 scores,respectively;comparisons in aspects on 6mWD and Minnesota score showed that the effectiveness with high dose is the most effective,moderate dose as the second,and low dose as the lowest(P0.01).Conclusions:AG was sufficient to display an optimal effect on improving heart contraction at the moderate dose.In aspects of improving the QOL of CHF patients,the effectiveness of AG showed a dosedependent trend.It should be applied discriminatively depending on the
Objective:To explore the dose-effect relationship of Astragalus granule(AG) on improving the quality of life(QOL) of the patients with chronic heart failure(CHF).Methods:Ninety CHF patients of Fei(肺)-qi deficiency and/or Xin(心)-Shen(肾) yang-deficiency syndromes were equally randomized divided with a random number table into three groups;they received the high(7.5 g),moderate(4.5 g),and low dosage(2.25 g) of AG orally taken twice a day,respectively,and 4 mg of perindopril tablet once a day for 30 successive days.The heart function grade,patients' left ventricular ejection fraction(LVEF) and walking distance in 6 min(6mWD) were measured before and after treatment,and the patients' QOL was scored by the Minnesota Questionnaire for QOL evaluation in the patients with CHF at the same time.Results:The heart function grades of all the three groups after treatment were improved compared with those before treatment,but the improvements in high-dose group and moderate dose group were better than that in the low dose group(P0.05).LVEFs were increased significantly in all the three groups,but the improvements in the high-dose group(59.42%±7.50%) and moderate dose group(61.98%±6.82%) were better than that in the low dose group(51.45%±6.80%,P0.01); the 6mWDs in the all groups were also significantly increased(P0.01),up to 419.80136.23 m,387.15134.13 m, and 317.69±39.97 m,respectively;and Minnesota scores in them were lowered to 29.59±4.69 scores,35.74±5.89 scores,and 42.78±6.06 scores,respectively;comparisons in aspects on 6mWD and Minnesota score showed that the effectiveness with high dose is the most effective,moderate dose as the second,and low dose as the lowest(P0.01).Conclusions:AG was sufficient to display an optimal effect on improving heart contraction at the moderate dose.In aspects of improving the QOL of CHF patients,the effectiveness of AG showed a dosedependent trend.It should be applied discriminatively depending on the
基金
Supported by the Funds of Scientific and Technological Research on Traditional Chinese Medicine,Traditional Chinese Medicine Administration of Jiangsu Province,China(No. HL07113)